The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculosis
Open accessAbstract
BACKGROUND: Recent evidence suggests that the duration of protection by bacillus Calmette-Guérin (BCG) may exceed previous estimates with potential implications for estimating clinical and cost-efficacy. OBJECTIVES: To estimate the protection and duration of protection provided by BCG vaccination against tuberculosis, explore how this protection changes with time since vaccination, and examine the reasons behind the variation in protection and the rate of waning of protection. DATA SOURCES: Electronic databases including MEDLINE, Excerpta Medica Database (EMBASE), Cochrane Databases, NHS Economic Evaluation Database (NHS EED), Database of Abstracts of Reviews of Effects (DARE), Web of Knowledge, Biosciences Information Service (BIOSIS), Latin American and Caribbean Health Sciences Literature (LILACs), MEDCARIB Database, Cumulative Index to Nursing and Allied Health Literature (CINAHL) were searched from inception to May 2009. Index to Theses, System for Information on Grey Literature in Europe (SIGLE), Centre for Agricultural Bioscience International (CABI) Abstracts, Scopus, Article First, Academic Complete, Africa-Wide Information, Google Scholar, Global Health, British National Bibliography for Report Literature, and clinical trial registration websites were searched from inception to October 2009. REVIEW METHODS: Electronic databases searches, screening of identified studies, data extraction and analysis were undertaken. Meta-analysis was used to present numerical and graphical summaries of clinical efficacy and efficacy by time since vaccination. Evidence of heterogeneity was assessed using the tau-squared statistic. Meta-regression allowed the investigation of observed heterogeneity. Factors investigated included BCG strain, latitude, stringency of pre-BCG vaccination tuberculin testing, age at vaccination, site of disease, study design and vulnerability to biases. Rate of waning of protection was estimated using the ratio of the measure of efficacy after 10 years compared with the efficacy in the first 10 years of a study. RESULTS: Study selection. A total of 21,030 references were identified, providing data on 132 studies after abstract and full-text review. Efficacy. Protection against pulmonary tuberculosis in adults is variable, ranging from substantial protection in the UK MRC trial {rate ratio 0.22 [95% confidence interval (CI) 0.16 to 0.31]}, to absence of clinically important benefit, as in the large Chingleput trial [rate ratio 1.05 (95% CI 0.88 to 1.25)] and greater in latitudes further away from the equator. BCG vaccination efficacy was usually high, and varied little by form of disease (with higher protection against meningeal and miliary tuberculosis) or study design when BCG vaccination was given only to infants or to children after strict screening for tuberculin sensitivity. High levels of protection against death were observed from both trials and observational studies. The observed protective effect of BCG vaccination did not differ by the strain of BCG vaccine used in trials. DURATION: Reviewed studies showed that BCG vaccination protects against pulmonary and extrapulmonary tuberculosis for up to 10 years. Most studies either did not follow up participants for long enough or had very few cases after 15 years. This should not be taken to indicate an absence of effect: five studies (one trial and four observational studies) provided evidence of measurable protection at least 15 years after vaccination. Efficacy declined with time. The rate of decline was variable, with faster decline in latitudes further from the equator and in situations where BCG vaccination was given to tuberculin-sensitive participants after stringent tuberculin testing. LIMITATIONS: The main limitation of this review relates to quality of included trials, most of which were conducted before current standards for reporting were formulated. In addition, data were lacking in some areas and the review had to rely on evidence from observational studies. CONCLUSIONS: BCG vaccination protection against tuberculosis varies between populations, to an extent that cannot be attributed to chance alone. Failure to exclude those already sensitised to mycobacteria and study latitude closer to the equator were associated with lower efficacy. These factors explained most of the observed variation. There is good evidence that BCG vaccination protection declines with time and that protection can last for up to 10 years. Data on protection beyond 15 years are limited; however, a small number of trials and observational studies suggest that BCG vaccination may protect for longer. Further studies are required to investigate the duration of protection by BCG vaccination. FUNDING: The National Institute for Health Research Health Technology Assessment programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Variation in protection by BCG: implications of and for heterologous immunity
Fine, P. E. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92348-9 · Cited by 1,380
Self-citationTrunz, B. B., Fine, P., & Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68507-3 · Cited by 1,114
Self-citationGlobal Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Whole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak
Gardy, J. L., Johnston, J. C., Sui, S. J. H., Cook, V. J., Shah, L., Brodkin, E., Rempel, S., Moore, R., Zhao, Y., Holt, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003176 · Cited by 712
Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis
RODRIGUES, L. C., DIWAN, V. K., & WHEELER, J. G. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.6.1154 · Cited by 650
Self-citationThe BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
Zwerling, A., Behr, M. A., Verma, A., Brewer, T. F., Menzies, D., & Pai, M. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001012 · Cited by 575
Genome plasticity of BCG and impact on vaccine efficacy
Brosch, R., Gordon, S. V., Garnier, T., Eiglmeier, K., Frigui, W., Valenti, P., Dos Santos, S., Duthoy, S., Lacroix, C., Garcia-Pelayo, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700869104 · Cited by 574
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Wallis, R. S., Pai, M., Menzies, D., Doherty, T. M., Walzl, G., Perkins, M. D., & Zumla, A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60359-5 · Cited by 453
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.271.9.698 · Cited by 355
Does the efficacy of BCG decline with time since vaccination?
Sterne, J. A. C., Rodrigues, L. C., & Guedes, I. N. (1998) · PubMed · Cited by 310
Self-citationBlack, G. F., Weir, R. E., Floyd, S., Bliss, L., Warndorff, D. K., Crampin, A. C., Ngwira, B., Sichali, L., Nazareth, B., Blackwell, J. M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08353-8 · Cited by 306
Self-citationKaufmann, S. H., Hussey, G., & Lambert, P.-H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60393-5 · Cited by 299
Rodrigues, L. C., Pereira, S. M., Cunha, S. S., Genser, B., Ichihara, M. Y., de Brito, S. C., Hijjar, M. A., Cruz, A. A., Sant'Anna, C., Bierrenbach, A. L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67145-0 · Cited by 286
Self-citationA historical and molecular phylogeny of BCG strains
Behr, M. A., & Small, P. M. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00277-1 · Cited by 242
Fine, P. E. M. (1996) · PubMed · Cited by 239
Self-citationEfficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
Ponnighaus, J. M., Msosa, E., Gruer, P. J. K., Liomba, N. G., Fine, P. E. M., Sterne, J. A. C., Wilson, R. J., Bliss, L., Jenkins, P. A., & Lucas, S. B. (1992) · The Lancet · doi:10.1016/0140-6736(92)90794-4 · Cited by 208
Self-citationBCG vaccination scar associated with better childhood survival in Guinea-Bissau
Roth, A., Gustafson, P., Nhaga, A., Djana, Q., Poulsen, A., Garly, M.-L., Jensen, H., Sodemann, M., Rodriques, A., & Aaby, P. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyh392 · Cited by 204
Assessment of BCG vaccination in India. Third Report. 1960.
Bhushan, K. (2013) · PubMed · Cited by 180
BCG vaccination against tuberculosis and leprosy
Fine, P. E. M. (1988) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072277 · Cited by 174
Self-citationChildhood cutaneous tuberculosis: a study over 25 years from northern India
Kumar, B., Rai, R., Kaur, I., Sahoo, B., Muralidhar, S., & Radotra, B. D. (2001) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2001.01165.x · Cited by 174
Clemens, J. D. (1983) · JAMA · doi:10.1001/jama.249.17.2362 · Cited by 151
Tuberculosis prevention Trial, Madras.
Baily, G. V. J. (1980) · PubMed · Cited by 131
BCG vaccination of Indian infants in Saskatchewan
Rg, F., & Simes, A. B. (1949) · Tubercle · doi:10.1016/s0041-3879(49)80055-9 · Cited by 124
The second Geneva Consensus: Recommendations for novel live TB vaccines
Walker, K. B., Brennan, M. J., Ho, M. M., Eskola, J., Thiry, G., SADOFF, J. C., Dobbelaer, R., Grode, L., Liu, M. A., Fruth, U., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.12.083 · Cited by 120
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy
Leung, A. S., Tran, V., Wu, Z., Yu, X., Alexander, D. C., Gao, G. F., Zhu, B., & Liu, J. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-413 · Cited by 109
Tuberculosis in the UK: Annual report on tuberculosis surveillance in the UK, 2009.
Moore, J. E., Crofts, J., Anderson, L., Bradshaw, L. E., Kruijshaar, M. E., & Abubakar, I. I. (2009) · Cited by 105
Self-citationSafety and efficacy of neonatal vaccination
Demirjian, A., & Levy, O. (2008) · European Journal of Immunology · doi:10.1002/eji.200838620 · Cited by 105
Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso
Vaugelade, J., Pinchinat, S., Guiella, G., Elguero, É., & Simondon, F. (2004) · BMJ · doi:10.1136/bmj.38261.496366.82 · Cited by 100
Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
Leung, C. C., Tam, C. M., Chan, S. L., et al. (2001) · PubMed · Cited by 94
Protective effect of BCG vaccination in infant Asians: a case-control study.
Packe, G. E., & Innes, J. A. (1988) · Archives of Disease in Childhood · doi:10.1136/adc.63.3.277 · Cited by 88
Eisenhut, M., Paranjothy, S., Abubakar, I., Bracebridge, S., Lilley, M., Mulla, R., Lack, K., Chalkley, D., & McEvoy, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.031 · Cited by 85
Self-citationProtective vaccination against tuberculosis with special reference to BCG vaccination.
Aronson, J. D. (1948) · PubMed · doi:10.1164/art.1948.58.3.255 · Cited by 82
Smith, P. G. (1982) · Tubercle · doi:10.1016/s0041-3879(82)80006-8 · Cited by 75
Self-citationYoung, T. K., & Hershfield, E. S. (1986) · American Journal of Public Health · doi:10.2105/ajph.76.7.783 · Cited by 71
INCIDENCE OF CHILDHOOD TUBERCULOSIS AFTER NEONATAL BCG VACCINATION
Curtis, H., Leck, I. M., & Bamford, F. N. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90072-2 · Cited by 66
Does the Protective Effect of Neonatal BCG Correlate With Vaccine-Induced Tuberculin Reaction?
Al‐Kassimi, F. A., Al‐Hajjaj, M. S., Al-Orainey, I. O. M., & Bamgboye, E. A. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.5.7582297 · Cited by 59
Miceli, I. N. P., Kantor, I. N., COLAIÁCOVO, D., et al. (1988) · International Journal of Epidemiology · doi:10.1093/ije/17.3.629 · Cited by 54
Does BCG vaccine prevent tuberculous meningitis?
Thilothammal, N., Krishnamurthy, P. V., Runyan, D. K., et al. (1996) · Archives of Disease in Childhood · doi:10.1136/adc.74.2.144 · Cited by 53
Effects of the human immunodeficiency virus on tuberculosis in children
Jeena, P. M., Mitha, T., Bamber, S., Wesley, A., Coutsoudis, A., & Coovadia, H. M. (1996) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(96)90117-3 · Cited by 53
A Case-Control Study of BCG and Childhood Tuberculosis in Cali, Colombia
Shapiro, C. A., Cook, N. R., Evans, D. A., Willett, W. C., Fajardo, I., KOCH-ESER, D., Bergonzoli, G., Bolaños, Ó., Guerrero, R., & Hennekens, C. H. (1985) · International Journal of Epidemiology · doi:10.1093/ije/14.3.441 · Cited by 52
Incidence of tuberculosis in young adult women, with special reference to employment
HEIMBECK, J. (1938) · British Journal of Tuberculosis · doi:10.1016/s0366-0850(38)80144-7 · Cited by 50
A community-wide tuberculosis study in a South Indian rural population, 1950-1955.
FRIMODT-MOLLER, J. (1960) · PubMed · Cited by 48
Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil.
Barreto, M. L., da Cunha, S. S., Pereira, S. M., Genser, B., Hijjar, M. A., Ichihara, M. Y., de Brito, S. C., Dourado, I. C., Cruz, A., Santa'Ana, C., et al. (2005) · PubMed · Cited by 46
Self-citationFactors associated with the development of tuberculosis in BCG immunized children.
Tipayamongkholgul, M., Podhipak, A., Chearskul, S., et al. (2005) · PubMed · Cited by 46
Camargos, P. A. M., Guimarães, M. D. C., & Antunes, C. (1988) · International Journal of Epidemiology · doi:10.1093/ije/17.1.193 · Cited by 45
Kruijshaar, M. E., Watson, J. M., Drobniewski, F. A., Anderson, C. S., Brown, T. J., Magee, J. G., Smith, E. G., Story, A., & Abubakar, I. (2008) · BMJ · doi:10.1136/bmj.39546.573067.25 · Cited by 41
Self-citationTuberculous meningitis in BCG vaccinated and unvaccinated children
Kumar, R. K. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.065201 · Cited by 40
Effectiveness of BCG vaccination against tuberculous meningitis.
Awasthi, S., & Moin, S. (1999) · PubMed · Cited by 38
Some evidence of the efficacy of mass BCG vaccination.
Bjartveit, K., & Waaler, H. T. (1965) · Europe PMC (PubMed Central) · Cited by 37
Divergence of immunologic and protective responses of different BCG strains in a murine model
Kozak, R. A., & Behr, M. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.12.012 · Cited by 34
Case-control study on evaluation of BCG vaccination of newborn in Rangoon, Burma
Myint, T.-T., Win, H., Aye, H. H., et al. (1987) · Annals of Tropical Paediatrics · doi:10.1080/02724936.1987.11748499 · Cited by 32
Tupasi, T. E., Radhakrishna, S., Pascual, M. L., et al. (2000) · PubMed · Cited by 31
BCG Study at a State School for Mentally Retarded
Bettag, O. L., Kaluzny, A., Morse, D. E., et al. (1964) · Diseases of the Chest · doi:10.1378/chest.45.5.503 · Cited by 27
Shaw, L. (1951) · Public Health Reports (1896-1970) · doi:10.2307/4587899 · Cited by 26
Protective effect of BCG vaccination in Norway 1956–1973
Tverdal, A., & Funnemark, E. (1988) · Tubercle · doi:10.1016/0041-3879(88)90074-8 · Cited by 23
Mayo, R. E. P., & Stanford, J. L. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90088-9 · Cited by 23
Ten years' experience with BCG (experimental and clinical)
Rosenthal, S. R., Blahd, M., & Leslif, E. I. (1945) · The Journal of Pediatrics · doi:10.1016/s0022-3476(45)80195-6 · Cited by 23
Clarke, A., & Rudd, P. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.4.473 · Cited by 22
(2001) · PubMed · Cited by 20
Pulickal, A. S., & Fernandez, G. V. J. (2007) · PubMed · Cited by 19
Hills, E. A., Sommer, A. R., Springett, V. H., et al. (1975) · Tubercle · doi:10.1016/0041-3879(75)90023-9 · Cited by 16
Fine, P. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401753382576 · Cited by 16
Self-citationEpidemiological evaluation of BCG vaccine efficacy in Delhi--1989.
Rs, S., Srivastava, D. K., Aa, S., et al. (1989) · PubMed · Cited by 15
A contact study to evaluate the BCG vaccination programme in Seoul
Jin, B. W., Hong, Y. P., & Kim, S. J. (1989) · Tubercle · doi:10.1016/0041-3879(89)90018-4 · Cited by 14
BCG Vaccination and Tuberculosis in Students of Nursing
Rosenthal, S. R., AFREMOW, M. L., Nikurs, L., et al. (1963) · AJN American Journal of Nursing · doi:10.2307/3452499 · Cited by 14
Lj, N., Naik, Y. G., Tsering, K., et al. (2005) · PubMed · Cited by 14
Tuberculosis among Dislocated North Koreans Entering Republic of Korea since 1999
Choi, C., June, J.-H., Kang, C., Park, J. T., Oh, S.-Y., Lee, J.-B., Lee, C., Yim, J., & Kim, H. J. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.6.963 · Cited by 12
Environmental influence on immunity due to B.C.G. vaccination.
Kp, M., Sm, M., & Korde, U. (1976) · PubMed · Cited by 10
Murhekar, M. V., Kulkarni, H. R., Zodpey, S. P., & Ag, D. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90532-4 · Cited by 8
First Results of the Field Use of Bcg Vaccine to Control Bovine Tuberculosis in Malawi
Ellwood, D. C. (1975) · British Veterinary Journal · doi:10.1016/s0007-1935(17)35339-3 · Cited by 8
Immunization against Tuberculosis. A Study of the Essential Factors.
Levine, M. I., Vogel, P., & Rosenberg, H. A. (1938) · American Review of Tuberculosis and Pulmonary Diseases · Cited by 6
Case series evaluation of BCG vaccine efficacy against tubercular meningitis in children in Delhi.
Bhattacharjee, J., Sharma, R., Singh, J., et al. (1993) · PubMed · Cited by 6
Assessment of efficacy of BCG vaccination among slum children of Agra City.
Mehrotra, A., Dabral, S. B., Nandan, D., et al. (1990) · PubMed · Cited by 6
Eilerlsen, E. (1968) · PubMed · Cited by 2
Cited by
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Factors That Influence the Immune Response to Vaccination
Zimmermann, P., & Curtis, N. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-18 · Cited by 939
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
Nemes, E., Geldenhuys, H., Rozot, V., Rutkowski, K. T., Ratangee, F., Bilek, N., Mabwe, S., Makhethe, L., Erasmus, M., Toefy, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714021 · Cited by 652
Walters, S. J., Bonacho dos Anjos Henriques-Cadby, I., Bortolami, O., Flight, L., Hind, D., Jacques, R. M., Knox, C., Nadin, B., Rothwell, J., Surtees, M., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015276 · Cited by 560
Roy, A., Eisenhut, M., Harris, R. J., Rodrigues, L. C., Sridhar, S., Habermann, S., Snell, L., Mangtani, P., Adetifa, I., Lalvani, A., et al. (2014) · BMJ · doi:10.1136/bmj.g4643 · Cited by 588
Self-citation
Metadata
- Authors
- Abubakar, I., Pimpin, L., Ariti, C., Beynon, R., Mangtani, P., Sterne, J., Fine, P., Smith, P., Lipman, M., Elliman, D., Watson, J., Drumright, L., Whiting, P., Vynnycky, E., & Rodrigues, L.
- Venue
- Health Technol Assess
- Published
- 2013-09
- Volume
- 17
- Issue
- 37
- Pages
- 1-372, v
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2058969608
- Cited by
- 498
- References
- 74
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.